CardiOCare's project logo

An Interdisciplinary Approach for the Management of the Elderly Multimorbid Patient with Breast Cancer Therapy Induced Cardiac Toxicity

Papers in international journals (full-paper reviewed)

  1. Brown C, Mantzaris M, Nicolaou E, et al. A systematic review of miRNAs as biomarkers for chemotherapy-induced cardiotoxicity in breast cancer patients reveals potentially clinically informative panels as well as key challenges in miRNA research. Cardio-Oncology. 2022;8(1):16. doi:10.1186/s40959-022-00142-1| Lay summary (in PDF)
  2. Gkikas S, Tsiknakis M. Automatic assessment of pain based on deep learning methods: A systematic review. Comput Methods Programs Biomed. 2023;231:107365. doi:10.1016/j.cmpb.2023.107365 | Lay summary (in PDF)
  3. Alexandraki A, Papageorgiou E, Zacharia M, et al. New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review. Cancers (Basel). 2023;15(13):3290. doi:10.3390/cancers15133290 | Lay summary (in PDF)

Conferences

Papers in Proceedings of International Conferences (full-paper reviewed)


  1. Tsiouris K, Mitsis A, Grigoriadis G, et al. Risk Stratification for Cardiotoxicity in Breast Cancer Patients: Predicting Early Decline of LVEF After Treatment. 2023 IEEE 45th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)

Papers in Proceedings of International Conferences (extended abstract reviewed)


  1. Casini C, Monzani D, Masiero M, et al. Incorporating psycho-social factors in cancer treatment adverse events studies. Ann Oncol. 2022;33:S1199. (poster presentation) doi:10.1016/j.annonc.2022.07.1535
  2. Karanasiou G, Grigoriadis G, Alexandraki A, et al. A multimodal approach for the management of co-morbid cardiotoxicity in the elderly breast cancer patients. Eur J Cancer. 2022;175:S40. (poster presentation) doi:10.1016/S0959-8049(22)01456-3

Poster presentations


  1. Casini C, Monzani D, Masiero M, et al. Incorporating psycho-social factors in cancer treatment adverse events studies. Ann Oncol. 2022;33:S1199. | Poster in PDF
  2. Karanasiou G, Grigoriadis G, Alexandraki A, et al. A multimodal approach for the management of co-morbid cardiotoxicity in the elderly breast cancer patients. Eur J Cancer. 2022;175:S40. | Poster in PDF
  3. Kalliatakis G, Manikis G, Karanasiou G, et al. Automated  Left Ventricular Ejection Fraction (LVEF) measurement in 2D Echocardiography using DL-based Segmentation. 2023 IEEE 20th International Symposium on Biomedical Imaging (ISBI) | Poster in PDF
  4. Karanasiou G, Koumakis L, Sfakianakis S, et. al. CARDIOCARE: An integrated platform for the management of elderly multimorbid patients with breast cancer therapy induced cardiac toxicity. 2023 IEEE 45th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) | Poster in PDF

Highlights

CARDIOCARE in IncontraDonna Conference

CARDIOCARE in IncontraDonna Conference

Prof. Ketti Mazzocco presented CARDIOCARE during her lecture in the IncontraDonna Conference "Care through Listening, Network, Transdisciplinarity, Empathy"  that was held on June, 11 2024 in Rome, Italy. The conference aimed to illustrate the therapeutic journey,...

CARDIOCARE in Heart and Cancer 2024

CARDIOCARE in Heart and Cancer 2024

Prof. Dimitrios Fotiadis, coordinator of CARDIOCARE, referred to the project in his presentation entitled "Artificial intelligence in prediction and early detection of cardiotoxicity (CARDIOCARE)" in Heart and Cancer 2024: Cardio-Oncology Update that took place from...

CARDIOCARE in the 1st Greek Forum on Cancer

CARDIOCARE in the 1st Greek Forum on Cancer

CARDIOCARE was presented in the Round-table "Digital Health" by Prof. Dimitrios Fotiadis, UOI, in the 1st Greek Forum on Cancer: Policy, Research & Funding Strategies. Moreover Prof. Manolis Tsiknakis, HMU, referred to CARDIOCARE in the Round-table "European...